Table 1.
Evaluation of the complete blood count parameters and selected ratios between individual groups (i.e., ASD, ADHD, and control groups) with respect to sex.
| Parameter | Controls a (n = 20) |
Control Females b (n = 5) |
Control Males c (n = 15) |
ASD d (n = 20) |
ASD Females e (n = 5) |
ASD Males f (n = 15) |
ADHD g (n = 20) | ADHD Females h (n = 5) |
ADHD Males i (n = 15) |
|---|---|---|---|---|---|---|---|---|---|
| WBC (109/L) | 6.18 ± 0.97 | 6.15 ± 0.46 | 6.19 ± 0.26 | 7.37 ± 1.89 | 6.64 ± 0.72 | 7.63 ± 0.53 | 7.21 ± 1.42 | 7.02 ± 0.33 | 7.28 ± 0.43 |
| Neu (109/L) |
2.78 ± 0.73 | 3.12 ± 0.40 | 2.66 ± 0.17 | 3.46 ± 1.19 | 3.13 ± 0.40 | 3.58 ± 0.34 | 3.50 ± 0.99 | 2.94 ± 0.41 | 3.66 ± 0.27 |
| Lym (109/L) |
2.56 (2.20, 3.01) | 2.21 (2.11, 2.45) | 2.62 (2.40, 3.13) | 2.63 (2.25, 3.59) | 2.46 (2.27, 2.73) | 2.65 (2.28, 3.59) | 2.90 (1.91, 3.73) | 3.28 (2.87, 4.36) | 2.71 (1.90, 3.40) |
| Mon (109/L) |
0.47 (0.40, 0.53) | 0.59 (0.50, 0.62) | 0.46 (0.39, 0.48) | 0.58 (0.49, 0.70) | 0.50 (0.41, 0.61) | 0.62 (0.50, 0.76) | 0.52 (0.42, 0.68) | 0.41 (0.38, 0.44) | 0.56 (0.45, 0.72) |
| PLT (109/L) |
277 (241, 297) | 277 (276, 300) | 266 (241, 295) | 313 (255, 345) | 331 (297, 365) | 296 (251, 344) | 302 (263, 348) | 288 (265, 331) | 303 (274, 352) |
| MPV (fL) |
8.55 ± 0.71 | 8.66 ± 0.43 | 8.52 ± 0.17 | 8.34 ± 0.81 | 7.68 ± 0.33 | 8.58 ± 0.19 | 8.61 ± 0.68 | 8.66 ± 0.32 | 8.59 ± 0.18 |
| PDW (%) |
16.60 ± 0.38 | 16.70 ± 0.10 | 16.60 ± 0.11 | 17.00 ± 0.83 | 16.90 ± 0.52 | 17.00 ± 0.20 | 17.30 ± 0.87 | 17.10 ± 0.47 | 17.30 ± 0.22 |
| NLR | 0.97 (0.80, 1.37) | 1.39 (1.36, 1.41) | 0.91 (0.80, 1.10) | 1.15 (1.02, 1.43) | 1.07 (0.98, 1.23) | 1.15 (1.07, 1.45) | 1.21 (0.91, 1.73) | 0.75 (0.57, 1.03) | 1.30 (0.98, 1.84) |
| PLR | 103.0 (85.4, 113.0) | 114.0 (113.0, 136.0) | 101.0 (83.1, 104.0) | 113.0 (99.7, 119.0) | 96.3 (85.9, 129.0) | 114.0 (110.0, 119.0) | 102.0 (72.1, 125.0) | 70.0 (66.1, 101.0) | 115.0 (84.8, 140.0) |
| LMR | 5.23 (4.56, 6.45) | 4.21 (3.58, 4.42) | 5.71 (4.88, 6.67) | 4.92 (3.64, 6.52) | 5.54 (4.92, 6.06) | 4.30 (3.34, 6.59) | 5.22 (4.17, 7.05) | 8.55 (7.00, 8.63) | 4.96 (3.91, 5.96) |
| MLR | 0.19 (0.16, 0.22) | 0.24 (0.23, 0.28) | 0.18 (0.15, 0.21) | 0.20 (0.15, 0.28) | 0.18 (0.17, 0.20) | 0.23 (0.15, 0.30) | 0.19 (0.14, 0.24) | 0.12 (0.12, 0.14) | 0.20 (0.17, 0.26) |
| PMR | 531 (466, 688) | 476 (445, 600) | 539 (493, 704) | 409 (370, 590) | 543 (454, 669) | 408 (372, 579) | 583 (415, 700) | 602 (565, 846) | 487 (404, 692) |
| MPVLR | −0.06 (−1.07, 2.82) | −1.01 (−1.23, −0.31) | 0.25 (−0.58, 2.88) | −0.59 (−1.36, 0.86) | −0.59 (−2.57, 1.58) | −0.78 (−1.29, 0.66) | −0.23 (−0.59, 0.59) | −0.20 (−0.25, 0.58) | −0.29 (−1.41, 0.47) |
| MPVPR | −1.28 (−1.95, 0.19) | −1.26 (−5.68, −0.74) | −1.29 (−1.95, 0.20) | −0.84 (−1.45, −0.49) | −1.37 (−1.41, −1.13) | −0.78 (−1.69, −0.25) | −0.10 (−1.13, 0.61) | 0.78 (0.28, 1.35) | −0.67 (−1.33, 0.57) |
ASD—autism spectrum disorder; ADHD—attention deficit/hyperactivity disorder; WBC- white blood cells; Neu—neutrophils; Lym—lymphocytes; Mon—monocytes; PLT—platelets; MPV—mean platelet volume; PDW—platelet distribution width; NLR—neutrophils to lymphocytes ratio; PLR—platelets to lymphocytes ratio; LMR—lymphocytes to monocytes ratio; MLR—monocytes to lymphocytes ratio; PMR—platelets to monocytes ratio; MPVLR—MPV to lymphocytes ratio; MPVPR—MPV to platelets ratio. Data are expressed as mean ± SD or median (interquartile range). a indicates the control group; b indicates the control females; c indicates the control males; d indicates the ASD group; e indicates the ASD females; f indicates the ASD males; g indicates the ADHD group; h indicates the ADHD females; i indicates the ADHD males.